ZTS
Zoetis Inc.
NYSEUSDEQUITY
Healthcare
DELAYED
Sell
-26/100
Last price
71.33
▼ 0.08 (0.11%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
71.60
Prev close
71.41
Day high
72.30
Day low
70.60
Volume
3.43M
Market cap
$29.48B
P/E (TTM)
11.75
52W range
68.77 – 148.30
Day trading desk
Gap from prior close
+0.27%
Prior close 71.41
VWAP
71.24
+0.13% from price
Relative volume
1.42×
Normal
Session range
2.42%
70.59 – 72.30
Position in range
43%
Mid range
ATR (14D)
1.83
2.56% of price
Prior day high
71.47
PDH
Prior day low
69.00
PDL
Bid / ask spread
—
Quote not published
Session volume
7.79M
Avg 5.49M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+1.47%
-0.5%
1M
-5.91%
-7.1%
3M
-5.02%
-9.5%
6M
-38.93%
-57.1%
YTD
-43.31%
-57.6%
1Y
-51.28%
-67.7%
3Y
-59.00%
-141.3%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on ZTS open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
677.69K
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 7, 26 | D AMELIO FRANK A Director |
STOCK | 6.65K | $0 | Direct |
| Jun 10, 26 | MCCALLISTER MICHAEL B Director |
STOCK | 1.21K | $0 | Direct |
| May 21, 26 | STETTER MARK Director |
— | 1.57K | — | Direct |
| May 20, 26 | PARENT LOUISE M Director |
— | 12.13K | — | Direct |
| May 13, 26 | BISARO PAUL M. Director |
BUY | 2.00K | $151.75K | Direct |
| May 13, 26 | D AMELIO FRANK A Director |
BUY | 6.65K | $501.34K | Direct |
| May 11, 26 | MCCALLISTER MICHAEL B Director |
BUY | 3.00K | $233.27K | Indirect |
| Apr 30, 26 | ESCH KEVIN PH.D. Officer |
— | 259 | — | Direct |
| Mar 31, 26 | SARBAUGH KEITH Officer |
— | 1.53K | — | Direct |
| Mar 9, 26 | NORDEN GREGORY Director |
STOCK | 1.21K | $0 | Direct |
| Feb 19, 26 | PARENT LOUISE M Director |
— | 1.62K | — | Direct |
| Feb 19, 26 | BISARO PAUL M. Director |
— | 1.62K | — | Direct |
| Feb 19, 26 | REED WILLIE M Director |
— | 1.62K | — | Direct |
| Feb 19, 26 | MCCALLISTER MICHAEL B Director |
— | 1.62K | — | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BISARO PAUL M. |
Director | 27.86K | Purchase |
D AMELIO FRANK A |
Director | 21.46K | Stock Gift |
JOSEPH WETTENY |
Chief Financial Officer | 20.77K | Conversion of Exercise of derivative security |
LAGANO ROXANNE |
Officer | 16.46K | Conversion of Exercise of derivative security |
MCCALLISTER MICHAEL B |
Director | 31.89K | Stock Gift |
NORDEN GREGORY |
Director | 18.17K | Stock Gift |
PARENT LOUISE M |
Director | 28.39K | Conversion of Exercise of derivative security |
PECK KRISTIN C |
Chief Executive Officer | 105.90K | Conversion of Exercise of derivative security |
REED WILLIE M |
Director | 12.86K | Conversion of Exercise of derivative security |
SCULLY ROBERT W |
Director | 29.08K | Conversion of Exercise of derivative security |
Fundamentals
Market cap$29.48B
Enterprise value$37.05B
Revenue (TTM)$9.53B
Gross profit$6.83B
EBITDA$4.07B
Net income$2.64B
EPS (TTM)$6.07
Free cash flow$2.02B
Total cash$1.68B
Total debt$9.26B
Book value / share—
Shares outstanding413.22M
Float412.37M
Short % of float4.76%
Dividend yield2.97%
Beta (5Y)0.74
Valuation & profitability ratios
Trailing P/E11.75
Forward P/E10.90
PEG ratio6.65
Price / sales—
Price / book—
EV / revenue3.89
EV / EBITDA9.11
Gross margin71.74%
Operating margin40.72%
Profit margin27.68%
Return on equity64.91%
Return on assets15.35%
Debt / equity294.00
Current ratio3.08
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $9.47B | $9.26B | $8.54B | $8.08B | +2.3% |
| Operating revenue | $9.47B | $9.26B | $8.54B | $8.08B | +2.3% |
| Cost of revenue | $2.67B | $2.72B | $2.56B | $2.45B | -1.9% |
| Gross profit | $6.80B | $6.54B | $5.98B | $5.63B | +4.0% |
| Research & development | $698.00M | $686.00M | $614.00M | $539.00M | +1.7% |
| Selling, general & admin | $2.38B | $2.32B | $2.15B | $2.01B | +2.6% |
| Total operating expense | $3.20B | $3.15B | $2.91B | $2.70B | +1.9% |
| Operating income | $3.60B | $3.39B | $3.07B | $2.93B | +6.0% |
| Net interest income | -$129.00M | -$119.00M | -$134.00M | -$171.00M | -8.4% |
| Pre-tax income | $3.36B | $3.13B | $2.94B | $2.66B | +7.2% |
| Tax provision | $687.00M | $637.00M | $596.00M | $545.00M | +7.8% |
| Net income | $2.67B | $2.49B | $2.34B | $2.11B | +7.5% |
| Net income to common | $2.67B | $2.49B | $2.34B | $2.11B | +7.5% |
| Basic EPS | 6.03 | 5.47 | 5.08 | 4.51 | +10.2% |
| Diluted EPS | 6.02 | 5.47 | 5.07 | 4.49 | +10.1% |
| EBIT | $3.58B | $3.36B | $3.17B | $2.88B | +6.7% |
| EBITDA | $4.07B | $3.85B | $3.67B | $3.34B | +5.6% |
| Basic shares | 443.40M | 454.20M | 461.20M | 468.90M | -2.4% |
| Diluted shares | 443.80M | 454.80M | 462.30M | 470.40M | -2.4% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $2.31B | $1.99B | $2.04B | $3.58B | +16.4% |
| Cash & short-term investments | $2.31B | $1.99B | $2.04B | $3.58B | +16.4% |
| Accounts receivable | $1.59B | $1.32B | $1.30B | $1.22B | +20.8% |
| Inventory | $2.43B | $2.31B | $2.56B | $2.35B | +5.4% |
| Total current assets | $6.77B | $5.99B | $6.34B | $7.51B | +13.1% |
| Property, plant & equipment | $3.97B | $3.61B | $3.43B | $2.97B | +9.9% |
| Goodwill & intangibles | $3.77B | $3.85B | $4.10B | $4.13B | -2.2% |
| Total assets | $15.47B | $14.24B | $14.29B | $14.93B | +8.6% |
| Total current liabilities | $2.23B | $3.41B | $1.89B | $3.17B | -34.5% |
| Current debt | — | $1.35B | $3.00M | $1.35B | — |
| Long-term debt | $9.04B | $5.22B | $6.56B | $6.55B | +73.2% |
| Total debt | $9.24B | $6.74B | $6.75B | $8.09B | +37.0% |
| Total liabilities | $12.14B | $9.47B | $9.29B | $10.52B | +28.2% |
| Retained earnings | $13.74B | $11.97B | $10.29B | $8.67B | +14.8% |
| Shareholder equity | $3.33B | $4.77B | $5.00B | $4.41B | -30.2% |
| Working capital | $4.53B | $2.57B | $4.45B | $4.34B | +76.1% |
| Net tangible assets | -$434.00M | $919.00M | $900.00M | $279.00M | -147.2% |
| Shares issued | 501.89M | 501.89M | 501.89M | 501.89M | 0.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $2.67B | $2.50B | $2.34B | $2.11B | +7.1% |
| Depreciation & amortisation | $487.00M | $497.00M | $491.00M | $465.00M | -2.0% |
| Stock-based compensation | $83.00M | $74.00M | $60.00M | $62.00M | +12.2% |
| Change in working capital | -$408.00M | $79.00M | -$512.00M | -$699.00M | -616.5% |
| Operating cash flow | $2.90B | $2.95B | $2.35B | $1.91B | -1.7% |
| Capital expenditure | -$621.00M | -$655.00M | -$732.00M | -$586.00M | +5.2% |
| Investing cash flow | -$748.00M | -$315.00M | -$777.00M | -$883.00M | -137.5% |
| Share buybacks | -$3.23B | -$1.86B | -$1.09B | -$1.59B | -74.1% |
| Dividends paid | -$889.00M | -$786.00M | -$692.00M | -$611.00M | -13.1% |
| Financing cash flow | -$1.87B | -$2.66B | -$3.11B | -$904.00M | +29.7% |
| Free cash flow | $2.28B | $2.30B | $1.62B | $1.33B | -0.7% |
| End cash position | $2.31B | $1.99B | $2.04B | $3.58B | +16.4% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $2.47B | $2.26B | $2.39B | $2.40B | $2.47B | +9.1% |
| Operating revenue | $2.47B | $2.26B | $2.39B | $2.40B | $2.47B | +9.1% |
| Cost of revenue | $673.00M | $641.00M | $712.00M | $683.00M | $664.00M | +5.0% |
| Gross profit | $1.79B | $1.62B | $1.68B | $1.72B | $1.81B | +10.7% |
| Research & development | $173.00M | $180.00M | $199.00M | $170.00M | $166.00M | -3.9% |
| Selling, general & admin | $592.00M | $588.00M | $619.00M | $579.00M | $614.00M | +0.7% |
| Total operating expense | $796.00M | $799.00M | $849.00M | $781.00M | $813.00M | -0.4% |
| Operating income | $999.00M | $822.00M | $826.00M | $936.00M | $997.00M | +21.5% |
| Net interest income | -$45.00M | -$41.00M | -$32.00M | -$32.00M | -$33.00M | -9.8% |
| Pre-tax income | $866.00M | $758.00M | $761.00M | $887.00M | $912.00M | +14.2% |
| Tax provision | $175.00M | $157.00M | $158.00M | $166.00M | $186.00M | +11.5% |
| Net income | $691.00M | $601.00M | $603.00M | $721.00M | $726.00M | +15.0% |
| Net income to common | $691.00M | $601.00M | $603.00M | $721.00M | $726.00M | +15.0% |
| Basic EPS | 1.65 | 1.42 | 1.38 | 1.63 | 1.61 | +16.2% |
| Diluted EPS | 1.65 | 1.42 | 1.37 | 1.63 | 1.61 | +16.2% |
| EBIT | $927.00M | $820.00M | $818.00M | $945.00M | $965.00M | +13.0% |
| EBITDA | $1.05B | $939.00M | $939.00M | $1.07B | $1.09B | +11.4% |
| Basic shares | 417.60M | 422.10M | 438.20M | 442.90M | 445.10M | -1.1% |
| Diluted shares | 417.70M | 422.40M | 438.60M | 443.20M | 445.50M | -1.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $1.47B | $1.94B | $2.31B | $2.08B | $1.44B | — | -24.1% |
| Cash & short-term investments | $1.67B | $1.94B | $2.31B | $2.08B | $1.44B | — | -13.8% |
| Accounts receivable | $1.57B | $1.51B | $1.59B | $1.54B | $1.54B | — | +4.3% |
| Inventory | $2.57B | $2.55B | $2.43B | $2.46B | $2.44B | — | +0.9% |
| Total current assets | $6.36B | $6.47B | $6.77B | $6.58B | $5.92B | — | -1.8% |
| Property, plant & equipment | $4.03B | $4.00B | $3.97B | $3.89B | $3.84B | — | +0.7% |
| Goodwill & intangibles | $3.69B | $3.74B | $3.77B | $3.80B | $3.83B | — | -1.3% |
| Total assets | $15.08B | $15.15B | $15.47B | $15.16B | $14.48B | — | -0.5% |
| Total current liabilities | $2.06B | $2.05B | $2.23B | $1.81B | $3.37B | — | +0.4% |
| Current debt | — | — | — | — | $1.35B | $1.35B | — |
| Long-term debt | $9.05B | $9.04B | $9.04B | $7.07B | $5.23B | — | +0.0% |
| Total debt | $9.24B | $9.24B | $9.24B | $7.27B | $6.79B | — | 0.0% |
| Total liabilities | $11.93B | $11.92B | $12.14B | $9.76B | $9.50B | — | +0.1% |
| Retained earnings | $14.65B | $14.18B | $13.74B | $13.59B | $12.87B | — | +3.3% |
| Shareholder equity | $3.15B | $3.23B | $3.33B | $5.40B | $4.98B | — | -2.6% |
| Working capital | $4.29B | $4.42B | $4.53B | $4.78B | $2.56B | — | -2.9% |
| Net tangible assets | -$541.00M | -$504.00M | -$434.00M | $1.59B | $1.14B | — | -7.3% |
| Shares issued | 414.15M | 501.89M | 501.89M | 501.89M | 501.89M | — | -17.5% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $691.00M | $601.00M | $603.00M | $742.00M | $726.00M | +15.0% |
| Depreciation & amortisation | $119.00M | $119.00M | $121.00M | $123.00M | $124.00M | 0.0% |
| Stock-based compensation | $26.00M | $25.00M | $22.00M | $22.00M | $22.00M | +4.0% |
| Change in working capital | -$158.00M | -$385.00M | $170.00M | -$7.00M | -$314.00M | +59.0% |
| Operating cash flow | $655.00M | $401.00M | $893.00M | $891.00M | $605.00M | +63.3% |
| Capital expenditure | -$117.00M | -$110.00M | -$161.00M | -$136.00M | -$146.00M | -6.4% |
| Investing cash flow | -$300.00M | -$87.00M | -$166.00M | -$167.00M | -$212.00M | -244.8% |
| Share buybacks | -$584.00M | -$606.00M | -$2.06B | -$394.00M | -$338.00M | +3.6% |
| Dividends paid | -$223.00M | -$224.00M | -$220.00M | -$222.00M | -$223.00M | +0.4% |
| Financing cash flow | -$813.00M | -$840.00M | -$495.00M | -$134.00M | -$564.00M | +3.2% |
| Free cash flow | $538.00M | $291.00M | $732.00M | $755.00M | $459.00M | +84.9% |
| End cash position | $1.48B | $1.94B | $2.31B | $2.08B | $1.63B | -24.0% |
Options analytics
Put / call volume
3.21
Put-heavy session
Put / call open interest
0.60
Positioning, not flow
Max pain
115.00
+61.2% from spot
ATM implied vol
0.0%
Nearest strike to spot
Skew (10% OTM)
0.0%
Calls bid over puts
Call volume
175
Contracts, this expiry
Put volume
561
Contracts, this expiry
Heaviest call OI
125.00
43 contracts
Heaviest put OI
115.00
37 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 1.85 | 1.87 | +1.0% |
| Mar 2026 | 1.62 | 1.53 | -5.3% |
| Dec 2025 | 1.40 | 1.48 | +5.5% |
| Sep 2025 | 1.62 | 1.70 | +4.8% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 1.51 | 13 | $2.30B | -4.2% |
| Next quarter | 1.30 | 12 | $2.22B | -6.9% |
| Current year | 6.21 | 14 | $9.24B | -2.4% |
| Next year | 6.54 | 16 | $9.48B | +2.6% |
Analyst targets & ownership
Mean target$96.00
High target$155.00
Low target$80.00
Implied upside34.59%
Analyst count14
ConsensusBUY
Strong buy / Buy4 / 4
Hold9
Sell / Strong sell0 / 0
Held by insiders0.16%
Held by institutions100.38%
Institutions holding2.04K
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
70.60
+1.03% from price
SMA 20
71.69
-0.51% from price
SMA 50
74.21
-3.88% from price
SMA 100
75.67
-5.74% from price
SMA 200
97.84
-27.09% from price
EMA 12
71.08
+0.36% from price
EMA 26
72.26
-1.29% from price
EMA 50
74.15
-3.81% from price
RSI (14)
45.5
Neutral
MACD (12,26,9)
-1.19
Hist 0.05
ATR (14)
1.83
2.56% of price
Realised vol 30D
22.4%
Annualised
Bollinger upper
74.39
20, 2σ
Bollinger lower
68.99
20, 2σ
50 / 200 cross
Death
74.21 vs 97.84
Trend bias
Below 200
-27.09%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.57
Less volatile than market
Correlation to SPY
0.19
Largely independent
Realised vol 30D
22.4%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-53.2%
Peak to trough
Max drawdown 5Y
-72.0%
Peak to trough
ATR 14
1.83
2.56% of price
Beta (reported)
0.74
5Y monthly, from filing
Short interest
Shares short
17.39M
Prior 16.78M
Change vs prior
+3.6%
Shorts adding
% of float
4.76%
Normal
% of shares out
4.21%
Against total outstanding
Days to cover
3.8
Liquid
Float
412.37M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 25, 26 | TD Cowen | MAINTAINED | Buy | Buy |
| Aug 20, 26 | Stifel | MAINTAINED | Hold | Hold |
| Aug 11, 26 | Citigroup | MAINTAINED | Buy | Buy |
| Aug 11, 26 | BNP Paribas | MAINTAINED | Outperform | Outperform |
| Aug 10, 26 | Piper Sandler | MAINTAINED | Neutral | Neutral |
| Aug 7, 26 | UBS | MAINTAINED | Neutral | Neutral |
| Aug 7, 26 | JP Morgan | MAINTAINED | Overweight | Overweight |
| Aug 6, 26 | William Blair | DOWNGRADE | Outperform | Market Perform |
| Jul 27, 26 | UBS | MAINTAINED | Neutral | Neutral |
| Jul 22, 26 | Morgan Stanley | MAINTAINED | Overweight | Overweight |
| Jul 6, 26 | HSBC | MAINTAINED | Buy | Buy |
| Jul 1, 26 | Barclays | MAINTAINED | Equal-Weight | Equal-Weight |
Dividends & splits
Forward rate$2.12 / yr
Forward yield2.97%
5-year avg yield0.91%
Payout ratio33.88%
Ex-dividend dateJul 20, 2026
Next pay dateSep 1, 2026
Last split—
Split date—
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-08-06
Annual report of employee stock purchase
11-K · 2026-06-22
Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)
SD · 2026-05-28
Corporate Changes & Voting Matters
8-K · 2026-05-22
Corporate Changes & Voting Matters
8-K · 2026-05-20
Corporate Changes & Voting Matters
8-K · 2026-05-07
Annual Report to Shareholders
ARS · 2026-04-08
Corporate Changes & Voting Matters
8-K · 2026-02-12
Headlines
Michael Burry Warns of Risks for These Stocks
GuruFocus.com · 15h ago
New Peer-Reviewed Publication on Laboratory Study That Demonstrated Simparica Trio® Protected 3x More Dogs From Infection With a Resistant Heartworm Isolate Than NexGard® Plus1
Business Wire · 18h ago
Zoetis (ZTS) Has a Huge Animal Health Moat. Is It Starting to Crack?
Insider Monkey · 5d ago
Zoetis (ZTS) Stock Sinks As Market Gains: Here's Why
Zacks · 5d ago
Zoetis (ZTS) Registers a Bigger Fall Than the Market: Important Facts to Note
Zacks · 12d ago
Zoetis to Host Webcast and Conference Call on Third Quarter 2026 Financial Results
Business Wire · 13d ago
Companion Animal Diagnostic Market Forecasts Growth from $3.56B (2026) to $5.40B by 2031, Profiling IDEXX Laboratories & Zoetis
GlobeNewswire · 13d ago
'Big Short' Michael Burry Tunes Out AI ‘Woo-Hoos’ — Finds Opportunity In Copper, QXO And 3 More Stocks
Stocktwits · 15d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.